T-cell therapies are not just for cancer. Researchers are also advancing immunotherapy methods to protect bone marrow transplant patients from viral infections. 

High-dose vitamin C injections reverse the effects of a leukemia-promoting genetic deficiency.

Scientists have estimated that about half of murine platelet production occurs in the lungs.

Artificial bones produce new blood cells in mice, obviating the need for irradiation to kill off resident hematopoietic stem cells in recipients.

Certain drugs could worsen graft-versus-host disease in stem cell transplant patients, scientists show.

The origins of adipocytes have been hotly debated, but a human study supports the idea that the bone marrow takes part. 

Adult sickle-cell patients have safely stopped taking their immunosuppressant medication thanks to a new type of blood stem-cell transplant.

Scientists come up with a simpler, more efficient strategy for making multivirus-targeting T cells for immunotherapy.

A report reveals that using bone marrow stem cells to treat heart disease is less promising than a decade of research has let on.

The virus is back in two patients in Boston who received bone-marrow transplants and did not have detectable levels of virus for months.